Monitoring Agency Reports for the quarter ended March 31, 2026 in compliance with Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
REFEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Refex Industries Limited has submitted Monitoring Agency Reports from CARE Ratings Limited to BSE and NSE, as required under SEBI regulations. The reports cover fund utilisation from two preferential issues: one involving equity shares and warrants to promoters (approved via EGM on March 27, 2024) and another involving equity shares and warrants to both promoters and non-promoters (approved via EGM on October 26, 2024). The filing is a routine compliance requirement under Regulation 32(6) of SEBI LODR Regulations and Regulation 162A(4) of SEBI ICDR Regulations. The actual utilisation details are contained in Annexures A and B attached to the filing. The reports are also available on the company's investor relations website.
This is a standard regulatory disclosure confirming that an independent monitoring agency is reviewing how funds from preferential share and warrant issuances are being deployed. No immediate impact on stock price, but investors should review the actual reports for any concerns about fund utilisation.